Acute iron intoxication: change in urine color during chelation therapy with deferoxamine

Author： Fernández Sara   Castro Pedro   Nogué Santiago   Nicolás Jose  

Publisher： Springer Publishing Company

ISSN： 0342-4642

Source： Intensive Care Medicine, Vol.40, Iss.1, 2014-01, pp. : 104-104

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Renal Dysfunction in Patients with Beta-Thalassemia Major Receiving Iron Chelation Therapy either with Deferoxamine and Deferiprone or with Deferasirox

By  

Acta Haematologica, Vol. 123, Iss. 3, 2010-02 ,pp. : 148-152

Karger

Access to resources Recommend Favorite

Safety and Efficacy of Combined Chelation Therapy with Deferasirox and Deferoxamine in a Gerbil Model of Iron Overload

By  

Acta Haematologica, Vol. 120, Iss. 2, 2008-11 ,pp. : 123-128

Karger

Access to resources Recommend Favorite

Another Step Forward in Iron Chelation Therapy

By  

Acta Haematologica, Vol. 134, Iss. 4, 2015-0 ,pp. : 231-232

Karger

Access to resources Recommend Favorite

Improvement in Hematopoiesis after Iron Chelation Therapy with Deferasirox in Patients with Aplastic Anemia

By  

Acta Haematologica, Vol. 129, Iss. 2, 2012-11 ,pp. : 72-77

Karger

Access to resources Recommend Favorite

Role of T2* Magnetic Resonance in Monitoring Iron Chelation Therapy

By  

Acta Haematologica, Vol. 122, Iss. 2-3, 2009-11 ,pp. : 146-154

Karger

Access to resources Recommend Favorite